-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – N-115 in Allergic Rhinitis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - N-115 in Allergic Rhinitis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. N-115 in Allergic Rhinitis Drug Details: N-115 (sodium pyruvate) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – N-115 in Pulmonary Fibrosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - N-115 in Pulmonary Fibrosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. N-115 in Pulmonary Fibrosis Drug Details: N-115 (sodium pyruvate) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – N-115 in Cystic Fibrosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - N-115 in Cystic Fibrosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. N-115 in Cystic Fibrosis Drug Details: N-115 (sodium pyruvate) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – N-115 in Idiopathic Pulmonary Fibrosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - N-115 in Idiopathic Pulmonary Fibrosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. N-115 in Idiopathic Pulmonary Fibrosis Drug Details: N-115 (sodium pyruvate) is...
-
Product Insights
Aminopeptidase N – Drugs In Development, 2023
Global Markets Direct’s Aminopeptidase N provides in depth analysis on Aminopeptidase N targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Aminopeptidase N targeted therapeutics development and features...
-
Product Insights
Nicotinamide N Methyltransferase – Drugs In Development, 2023
Global Markets Direct’s Nicotinamide N Methyltransferase provides in depth analysis on Nicotinamide N Methyltransferase targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Nicotinamide N Methyltransferase targeted therapeutics...
-
Product Insights
Alpha N-Acetylglucosaminidase – Drugs In Development, 2023
Global Markets Direct’s Alpha N-Acetylglucosaminidase provides in depth analysis on Alpha N-Acetylglucosaminidase targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Alpha N-Acetylglucosaminidase targeted therapeutics development and features...
-
Product Insights
N Sulphoglucosamine Sulphohydrolase – Drugs In Development, 2023
Global Markets Direct’s N Sulphoglucosamine Sulphohydrolase provides in depth analysis on N Sulphoglucosamine Sulphohydrolase targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in N Sulphoglucosamine Sulphohydrolase targeted therapeutics...
-
Product Insights
Protein Arginine N Methyltransferase 5 – Drugs In Development, 2023
Global Markets Direct’s Protein Arginine N Methyltransferase 5 provides in depth analysis on Protein Arginine N Methyltransferase 5 targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Protein...
-
Product Insights
Histone Lysine N Methyltransferase EZH2 – Drugs In Development, 2023
Global Markets Direct’s Histone Lysine N Methyltransferase EZH2 provides in depth analysis on Histone Lysine N Methyltransferase EZH2 targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Histone...